subsys

Subscribe to Breaking News Alerts

Pharmaceutical Executive John Kapoor Sentenced To 66 Months In Prison In Opioid Trial

Insys Therapeutics founder John Kapoor was convicted in a bribery and kickback scheme that prosecutors said helped fuel the opioid crisis. Charles Krupa/AP hide caption

toggle caption

Charles Krupa/AP

Law

Pharmaceutical Executive John Kapoor Sentenced To 66 Months In Prison In Opioid Trial

January 23, 2020 • His sentencing is the culmination of a months-long criminal trial that resulted in the first successful prosecution of pharmaceutical executives tied to the opioid epidemic.

Pharmaceutical Executive John Kapoor Sentenced To 66 Months In Prison In Opioid Trial

Listen · 3:26 3:26

Download
Embed <iframe src="https://www.npr.org/player/embed/798973304/799163609" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
Transcript

Insys Files For Chapter 11, Days After Landmark Opioid Settlement Of $225 Million

Insys Therapeutics founder John Kapoor departs federal court in Boston, Jan. 30. On Monday the company filed for Chapter 11 bankruptcy, saying it needs to sell its assets to pay back creditors. Kapoor, who was convicted last month of racketeering, owns more than 63% of the company. Steven Senne/AP hide caption

toggle caption

Steven Senne/AP

Law

Insys Files For Chapter 11, Days After Landmark Opioid Settlement Of $225 Million

June 10, 2019 • The maker of a highly addictive fentanyl-based drug wants to sell its assets to pay some $250 million in debts. The move could let the company out of part of the settlement deal reached last week.